A recently approved diabetes drug being clinically investigated for its effects on body weight in obese and overweight people has delivered 'substantial and sustained reductions in body weight' in a phase 3 clinical trial, according to results now pu
That approval was granted on the back of
The participants received tirzepatide or a placebo over the course of 72 weeks, along with support to follow a reduced-calorie diet and increase their levels of physical activity.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Overweight people lost 35 to 52 pounds on newly approved diabetes drug, study saysA recently approved drug for diabetes that helped users lose weight was also tested on overweight people without diabetes, with 'impressive' results that rival weight loss surgery, experts say.
Leer más »
Overweight people lost 35 to 52 pounds on newly approved diabetes drug, study saysA recently approved drug for diabetes that helped users lose weight was also tested on overweight people without diabetes, with 'impressive' results that rival weight loss surgery, experts say.
Leer más »
Diabetes drug lead to significant weight loss in people with obesity: studyObese participants in a weekly trial found that taking a diabetes drug led to dramatic weight loss, indicating the drug may be a game-changer
Leer más »
Diabetes drug helps patients lose never-before-seen amounts of weight, study showsA study of the Type 2 diabetes drug tirzepatide found it resulted in dramatic weight loss, offering hope for those struggling with obesity.
Leer más »
Ultrasounds Could Restore Human Memory and Reverse DementiaUltrasounds could reverse memory loss in Alzheimer's patients! And it might be further enhanced when combined with a new FDA-approved drug.
Leer más »
One of Most Bullish Days for Ethereum: $750 Million Shorts Liquidated from Market$ETH saw around $800 million of short liquidations as the coin manages to bounce from fundamental support level
Leer más »